Strand Life Sciences Launches Portal to Help Doctors with Rare Disease Diagnosis; Offers Discounted Testing for Low-Income Patients

Bengaluru, February 28, 2025: On the occasion of Rare Disease Day, Strand Life Sciences, a Reliance Industries subsidiary and leading genomics company today launched the StrandOmics Portal to

improve diagnosis of rare diseases.

This new online portal gives clinicians quick and easy access to information on genetic variants, giving them a comprehensive view for each case. This means faster and more accurate diagnosis for patients. In

addition to the portal, Strand Life Sciences will offer rare

disease genetic testing at a reduced cost for patients from economically disadvantaged backgrounds, making these crucial tests more accessible.

The StrandOmics Portal helps doctors by:

• Providing clear and quick genetic insights for better diagnosis

• Allowing doctors to independently review a broader set of genetic variants

• Improving prenatal diagnosis through better collaboration between specialists

  Dr Ramesh Hariharan, CEO & Co-Founder of Strand Life Sciences, said, “We are dedicated to improving genetic diagnostics and making it available to everyone. We will continue to innovate and

  invest in tools like the StrandOmics Portal to empower

  doctors in their fight against rare diseases.”

  About Strand Life Sciences

  Strand Life Sciences, a subsidiary of Reliance Industries Limited, is a genomics-based research and diagnostics company that combines a long track record in bioinformatics with cutting-edge laboratory

  assays and a vast hospital partner network to drive newer

  generations of patient care. Strand’s customers include global medical instruments, diagnostic, and pharmaceutical companies.Strand is also a pioneer of genomic testing in India, and its long global

  bioinformatics track record makes it the most trusted company

  for genomic diagnostics in the areas of oncology, rare diseases, women’s health, and infectious diseases.

  Additionally, Strand is actively expanding into consumer genomics, empowering individuals with personalized insights into their genetic makeup. For more information, visit https://strandls.com